SOLUBLE EPOXIDE HYDROLASE INHIBITORS FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION
                        
                            
                                申请人:Aavula Bhasker R.
                            
                            
                                公开号:US20090247521A1
                            
                            
                                公开(公告)日:2009-10-01
                            
                            The present invention generally relates to methods useful for a therapy using a class of urea or amide compounds and related compositions, wherein the compound is a soluble epoxide hydrolase inhibitor, for treating and ameliorating the symptoms of diseases related to endothelial dysfunction.